Uses of Ammusone

Ammuson is used to relieve respiratory mucus in the following specific cases:
Acute and chronic diseases of the respiratory tract accompanied by abnormal bronchial secretions. Chronic bronchitis Asthma-type bronchitis Ammuson is not used in the following cases:
The patient is allergic to Ambroxol hydrochloride or other ingredients of the drug. The patient has a progressive peptic ulcer.

Ammuson is made in the form of tablets and is taken with water after eating. Dosage of Ammuson is as follows:
Adults and children over 10 years old: 30 - 60mg Ambroxol hydrochloride/time, 2 times/day. Children 5 - 12 years old: 15 - 30mg Ambroxol hydrochloride / time, 2 times a day.

Ammuson when used together with some of the following drugs may cause drug interactions as follows:
Taking Ambroxol hydrochloride with antibiotics such as Doxycycline, Amoxicillin, Cefuroxim, Erythromycin, ... may increase the concentration antibiotic levels in the lung parenchyma. Do not combine Ambroxol hydrochloride with an antitussive such as Codeine or a expectorant such as Atropin. There are currently no reports of Ammuson drug interactions with other drugs in clinical practice. To ensure safety, patients should list all medications they are taking and any other medical conditions they are experiencing for their doctor or pharmacist to know the most appropriate medication direction, to avoid unwanted drug interactions. want to happen.

Ammuson is well tolerated. However, in the process of using Ammuson, patients may experience some unwanted side effects after injection, which are usually mild such as:
Nausea / vomiting, heartburn, indigestion. Allergic reactions, mainly rash (rare) Acute and severe anaphylactoid reactions, dry mouth, elevated transaminases (rare) Patients should inform their pharmacist or doctor of any undesirable effects right when using Ammuson .

Here are some notes when using Ammuson to treat:
Attention should be paid to patients who cough up blood and have gastrointestinal ulcers because ambroxol can dissolve fibrin clots and cause bleeding again. Ammuson contains lactose monohydrate - used as an inactive ingredient, caution should be exercised in patients with rare hereditary problems of lactose intolerance due to intestinal lactase deficiency or glucose-galactose malabsorption due to possible lead to abdominal pain, flatulence, diarrhea, malaise. There are no accurate reports of adverse effects when taking the drug during pregnancy. However, caution should be exercised when taking Ammuson during the first trimester of pregnancy. There is no information on the concentration of Ambroxol hydrochloride in breast milk. Only a short course of Ambroxol hydrochloride treatment did not help with the need for re-examination. There have been some (rare) reports of serious reactions when taking Ammuson. If the patient while taking the drug has the above symptoms appear on the skin or mucous membranes, discontinue the drug and treat appropriately. Effects of Ambroxol hydrochloride when driving or operating machinery.